Human induced pluripotent stem cell-derived hepatocytes for toxicology testing

Abstract excerpt

The need for more predictive in vitro toxicity models is a critical deficit in current preclinical pipeline safety evaluations. Current models employing tumor-derived cancer cell lines and isolated primary human hepatocytes (PHHs) afford an approximation of overt cytotoxicity but do not provide hepatotoxicity prediction owing to liabilities in metabolic activity along with phenotypic variability and instability...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 3D Printing in Biomedical Research
• Share to Biomedical Ethics and Regulation
• Share to Pluripotent Stem Cells Research